Ethical challenges in long-term funding for HIV/AIDS

Health Affairs

Volumn 28, Issue 6, 2009, Pages 1666-1676

  Brock, Dan W ^a   Wikler, Daniel ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALTRUISM; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; HEALTH CARE FINANCING; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MEDICAL ETHICS; NONHUMAN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-RETROVIRAL AGENTS; BIOETHICAL ISSUES; COST-BENEFIT ANALYSIS; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; PREVENTIVE HEALTH SERVICES; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 77949987676     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.28.6.1666     Document Type: Conference Paper

References (14)

1. World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. September 2009 progress report. Geneva (Switzerland): WHO; 2009 Sep [cited 2009 Sep 20]. Available from: httpy/wwwwho.int/hiv/mediacentre/tuapr2009-ru-en.pdf
2. Canning D. The economics of HIV/AIDS in low-income countries: the case for prevention. Cambridge (MA): Program on the Global Demography of Aging, Harvard School of Public Health; 2006 Apr. Working Paper Series no. 18.
3. Marseille E, Hofmann PB, Kahn JG. HIV prevention before HAART in sub-Saharan Africa. Lancet. 2002; 359(9320):1851-6.
4. Jonsen A. Bentham in a box: technology assessment and health care allocatioa Law Med Health Care. 1986;14(3-4):172-4.
5. Hadorn DC. Setting health care priorities in Oregon: cost-effectiveness meets the rule of rescue. JAMA. 1991;265(17):2218-25.
6. McKie J, Richardson J. The rule of rescue. Sec Sci Med. 2003;56(12):2407-19.
7. Glover J. Humanity, a moral history of the twentieth century. New Haven (CT): Yale University Press; 2001.
8. Weak A. Statistical lives and the principle of maximum benefit. J Med Ethics. 1979;5 (5):185-95.
9. Hammitt J, Treich N. Statistical vs. identified lives in benefit-cost analysis. J Risk Uncertainty. 2007;35 (1):45-66.
10. Keder EB, Cretin S. Discounting of life-saving and other non-monetary effects. Management Science. 1983;29(3):300-6.
11. Scheffler S. The rejection of consequentialism. Oxford (UK): Oxford University Press; 1988.
12. Brock DW. Priority to the worst off in health care resource prioritization. In: Battin M, Rhodes R, Silvers A, editors. Medicine and social justice. New York (NY): Oxford University Press; 2002. p. 362-72.
13. Kamm FR. Morality/mortality. Vol. I. Death and whom to save from it. Oxford (UK): Oxford University Press; 1993.
14. Brock DW. Ethical issues in the use of cost-effectiveness analysis in health care resource prioritization. In: Anand S, Peter F, Sen A, editors. Public health, ethics, and equity. Oxford (UK): Oxford University Press; 2004. p. 201-23.